Incidence of chemotherapy-induced nausea and vomiting (CINV) after highly and moderately emetogenic therapy in the era of NK-1 inhibitors - perception versus reality

被引：0
|
作者：
Perez-Altozano, J. [1 ]
Majem, M. [1 ]
Calvo, N. [1 ]
Moreno, E. [1 ]
Feliu, A. [1 ]
Gich, I. [1 ]
Mangues, A. [1 ]
Barnadas, A. [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70629-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [31] Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
    Ai Gao
    Shasha Guan
    Yinjuan Sun
    Lingling Wang
    Fanlu Meng
    Xia Liu
    Liyan Gu
    Guo Li
    Diansheng Zhong
    Linlin Zhang
    BMC Cancer, 23
  • [32] Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy - Comparison of ondansetron, prochlorperazine, and dexamethasone
    Lindley, C
    Goodin, S
    McCune, J
    Kane, M
    Amamoo, MA
    Shord, S
    Pham, T
    Yowell, S
    Laliberte, K
    Schell, M
    Bernard, S
    Socinski, MA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (03): : 270 - 276
  • [33] Incidence of chemotherapy-induced nausea and vomiting among cancer patients receiving moderately to highly emetogenic chemotherapy in cancer centers in Sichuan, China
    Sun, Yu
    Zheng, Yuzhu
    Yang, Xiaoyun
    Xie, Ke
    Du, Chi
    He, Lang
    Gui, Yan
    Fu, Jiangping
    Li, Changlin
    Zhang, Huiling
    Zhu, Li
    Bie, Jun
    Sun, Yi
    Fu, Yu
    Zhou, Yangang
    Shou, Feng
    Wang, Yan
    Zhu, Jiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2701 - 2708
  • [34] Incidence of chemotherapy-induced nausea and vomiting among cancer patients receiving moderately to highly emetogenic chemotherapy in cancer centers in Sichuan, China
    Yu Sun
    Yuzhu Zheng
    Xiaoyun Yang
    Ke Xie
    Chi Du
    Lang He
    Yan Gui
    Jiangping Fu
    Changlin Li
    Huiling Zhang
    Li Zhu
    Jun Bie
    Yi Sun
    Yu Fu
    Yangang Zhou
    Feng Shou
    Yan Wang
    Jiang Zhu
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2701 - 2708
  • [35] SAFETY AND EFFICACY OF ORAL PALONOSETRON IN PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) OVER MULTIPLE CYCLES OF MODERATELY EMETOGENIC CHEMOTHERAPY (MEC)
    Voisin, D.
    Grunberg, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 507 - 507
  • [36] Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study
    Simhadri, Soumya
    Dayyala, Sowmya
    Musinipally, Anjani Devi
    Guram, Lavanya
    Madavi, Mamatha
    Kancha, Ramakrishna
    Puligundla, Krishna Chaitanya
    SOUTH ASIAN JOURNAL OF CANCER, 2024,
  • [37] Prospective observational study on chemotherapy-induced nausea and vomiting (CINV) for cancer patients who were to receive moderately and highly emetogenic chemotherapy (MEC and HEC) and primary care medical staffs' perception on CINV by the CINV Study Group of Japan
    Tamura, K.
    Aiba, K.
    Saeki, T.
    Nakanishi, Y.
    Kamura, T.
    Baba, H.
    Yoshida, K.
    Yamamoto, N.
    Kitagawa, Y.
    Maehara, Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S271 - S271
  • [38] Incidence of chemotherapy-induced nausea and emesis after modern antiemetics - Perception versus reality
    Grunberg, SM
    Deuson, RR
    Mavros, P
    Geling, O
    Hansen, M
    Cruciani, G
    Daniele, B
    De Pouvourville, G
    Rubenstein, EB
    Daugaard, G
    CANCER, 2004, 100 (10) : 2261 - 2268
  • [39] Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy
    Rapoport, Bernardo
    Schwartzberg, Lee
    Chasen, Martin
    Powers, Dan
    Arora, Sujata
    Navari, Rudolph
    Schnadig, Ian
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : 23 - 30
  • [40] Aprepitant (APR) for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC) in breast and non-breast cancers
    Gralla, R.
    Rapoport, B.
    Brown, C.
    Street, J. C.
    Hardwick, J. S.
    Carides, A. D.
    EJC SUPPLEMENTS, 2009, 7 (03): : 23 - 24
12345